At the molecular level, RA could suppress proinflammatory cytokines and inflammatory mediators by inhibiting the NF-kB/STAT3 signaling pathway, which has been confirmed by the use of commercial RA in colitis mice [34]. This evidence concerns the gene NFKB1 and colitis.